|Home | About | Journals | Submit | Contact Us | Français|
Conceived and designed the experiments: FL MK. Analyzed the data: FL FvdL CS GZ MMC AW OL SB. Contributed reagents/materials/analysis tools: MK RB NGM TP TDS AH AGU MAI. Data preparation: FvdL PGH MdB AW MAI AvdL FR AGU AH WJN GH GdZ KLM PMT AD RP KH LB ZP SEM GWM MJW TDS TP NGM RB. Wrote the manuscript: FL MK. Additional contributions: CW FvdL AW NGM CS MMC OL MAI SB TDS TP RB. Approved the manuscript: FL FvdL CS GZ MMC PGH AW OL MdB MAI AvdL FR AGU AH WJN GH GdZ KLM PMT AD RP KH LB ZP SEM GWM MJW CW SB TDS TP NGM RB MK.
Inter-individual variation in facial shape is one of the most noticeable phenotypes in humans, and it is clearly under genetic regulation; however, almost nothing is known about the genetic basis of normal human facial morphology. We therefore conducted a genome-wide association study for facial shape phenotypes in multiple discovery and replication cohorts, considering almost ten thousand individuals of European descent from several countries. Phenotyping of facial shape features was based on landmark data obtained from three-dimensional head magnetic resonance images (MRIs) and two-dimensional portrait images. We identified five independent genetic loci associated with different facial phenotypes, suggesting the involvement of five candidate genes—PRDM16, PAX3, TP63, C5orf50, and COL17A1—in the determination of the human face. Three of them have been implicated previously in vertebrate craniofacial development and disease, and the remaining two genes potentially represent novel players in the molecular networks governing facial development. Our finding at PAX3 influencing the position of the nasion replicates a recent GWAS of facial features. In addition to the reported GWA findings, we established links between common DNA variants previously associated with NSCL/P at 2p21, 8q24, 13q31, and 17q22 and normal facial-shape variations based on a candidate gene approach. Overall our study implies that DNA variants in genes essential for craniofacial development contribute with relatively small effect size to the spectrum of normal variation in human facial morphology. This observation has important consequences for future studies aiming to identify more genes involved in the human facial morphology, as well as for potential applications of DNA prediction of facial shape such as in future forensic applications.
Monozygotic twins look more alike than dizygotic twins or other siblings, and siblings in turn look more alike than unrelated individuals, indicating that human facial morphology has a strong genetic component. We quantitatively assessed human facial shape phenotypes based on statistical shape analyses of facial landmarks obtained from three-dimensional magnetic resonance images of the head. These phenotypes turned out to be highly promising for studying the genetic basis of human facial variation in that they showed high heritability in our twin data. A subsequent genome-wide association study (GWAS) identified five candidate genes affecting facial shape in Europeans: PRDM16, PAX3, TP63, C5orf50, and COL17A1. In addition, our data suggest that genetic variants associated with NSCL/P also influence normal facial shape variation. Overall, this study provides novel and confirmatory links between common DNA variants and normal variation in human facial morphology. Our results also suggest that the high heritability of facial phenotypes seems to be explained by a large number of DNA variants with relatively small individual effect size, a phenomenon well known for other complex human traits, such as adult body height.
The morphogenesis and patterning of the face is one of the most complex events in mammalian embryogenesis. Signaling cascades initiated from both facial and neighboring tissues mediate transcriptional networks that act to direct fundamental cellular processes such as migration, proliferation, differentiation and controlled cell death. The complexity of human facial development is reflected in the high incidence of congenital craniofacial anomalies, and almost certainly underlies the vast spectrum of subtle variation that characterizes facial appearance in the human population.
Facial appearance has a strong genetic component; monozygotic (MZ) twins look more similar than dizygotic (DZ) twins or unrelated individuals. The heritability of craniofacial morphology is as high as 0.8 in twins and families , , . Some craniofacial traits, such as facial height and position of the lower jaw, appear to be more heritable than others , , . The general morphology of craniofacial bones is largely genetically determined and partly attributable to environmental factors –. Although genes have been mapped for various rare craniofacial syndromes largely inherited in Mendelian form , the genetic basis of normal variation in human facial shape is still poorly understood. An appreciation of the genetic basis of facial shape variation has far reaching implications for understanding the etiology of facial pathologies, the origin of major sensory organ systems, and even the evolution of vertebrates , . In addition, it is feasible to speculate that once the majority of genetic determinants of facial morphology are understood, predicting facial appearance from DNA found at a crime scene will become useful as investigative tool in forensic case work . Some externally visible human characteristics, such as eye color – and hair color , can already be inferred from a DNA sample with practically useful accuracies.
In a recent candidate gene study carried out in two independent European population samples, we investigated a potential association between risk alleles for non-syndromic cleft lip with or without cleft palate (NSCL/P) and nose width and facial width in the normal population . Two NSCL/P associated single nucleotide polymorphisms (SNPs) showed association with different facial phenotypes in different populations. However, facial landmarks derived from 3-Dimensional (3D) magnetic resonance images (MRI) in one population and 2-Dimensional (2D) portrait images in the other population were not completely comparable, posing a challenge for combining phenotype data. In the present study, we focus on the MRI-based approach for capturing facial morphology since previous facial imaging studies by some of us have demonstrated that MRI-derived soft tissue landmarks represent a reliable data source , .
In geometric morphometrics, there are different ways to deal with the confounders of position and orientation of the landmark configurations, such as (1) superimposition ,  that places the landmarks into a consensus reference frame; (2) deformation –, where shape differences are described in terms of deformation fields of one object onto another; and (3) linear distances , , where Euclidean distances between landmarks instead of their coordinates are measured. Rationality and efficacy of these approaches have been reviewed and compared elsewhere –. We briefly compared these methods in the context of our genome-wide association study (GWAS) (see Methods section) and applied them when appropriate.
We extracted facial landmarks from 3D head MRI in 5,388 individuals of European origin from Netherlands, Australia, and Germany, and used partial Procrustes superimposition (PS) , ,  to superimpose different sets of facial landmarks onto a consensus 3D Euclidean space. We derived 48 facial shape features from the superimposed landmarks and estimated their heritability in 79 MZ and 90 DZ Australian twin pairs. Subsequently, we conducted a series of GWAS separately for these facial shape dimensions, and attempted to replicate the identified associations in 568 Canadians of European (French) ancestry with similar 3D head MRI phenotypes and additionally sought supporting evidence in further 1,530 individuals from the UK and 2,337 from Australia for whom facial phenotypes were derived from 2D portrait images.
Characteristics of the study cohorts from The Netherlands (RS1, RS2), Australia (QTIMS, BLTS), Germany (SHIP, SHIP-TREND), Canada (SYS) and the United Kingdom (TwinsUK) are provided in Table 1. All participants included in this study were of European ancestry. Facial landmarks in the discovery cohorts RS1, RS2, QTIMS, SHIP, and SHIP-TREND were derived from directly comparable 3D head MRIs analyzed using the very same method (Figure 1). Similar 3D MRIs were available in SYS but the phenotyping method used here was slightly different (see Method). For the BLTS and TwinsUK cohorts, facial landmarks were derived from 2D portrait photos. The SYS (mean age 15 years), QTIMS (mean age 23 years), and BLTS (mean age 23 years) cohorts were on average much younger than other cohorts considered (mean age over 50 years, Table 1). The majority of the TwinsUK cohort was female (95.5%).
For 3D MRI based phenotyping, we focused on the nine most well-defined landmarks from the upper part of the face, including Zygion Right (ZygR), Zygion Left (ZygL), Eyeball Right (EyeR), Eyeball Left (EyeL), Alare Right (AlrR), Alare Left (AlrL), Nasion (Nsn), Pronasale (Prn), and Subnasale (Sbn) (Figure 1). The lower part of the face i.e., from underneath the nose further down was not available due to brain-focussed MRI scanning. Raw landmark coordinates from 5,388 individuals in the five discovery cohorts (RS1, RS2, QTIMS, SHIP, and SHIP-TREND) showed systematic differences in position and orientation (Figure 2A). They were superimposed onto a consensus 3D Euclidean space based on partial PS (Figure 2B). A total of 27 principal components (PCs), and the centroid size parameter, were derived from the superimposed landmarks. Eleven PCs, each explaining >1% and all together explaining 96.0% of the total shape variance, were selected for further genetic association analysis (Table S1). Furthermore, we derived 36 Euclidean distances between each pair of landmarks. The partial PS had no effect on inter-landmark distances i.e., the distances remain the same after the superimposition. We derived the phenotypic correlations in discovery cohorts containing only adults or young adults. The SYS cohort was excluded from this correlation analysis because the changes through adolescence may confound the effect of age. Centroid size was highly correlated with the first PC (r=0.96, Table S1) as well as with all 36 inter-landmark distances (mean r=0.76; minimal r=0.56 for Prn-Sbn; maximal r=0.94 for ZygR-AlrL; Table S2). Inter-landmark distances were also correlated with each other (mean r=0.56; minimal r=0.10 between EyeL-AlrL and ZygL-EyeL; maximal r=0.96 between AlrR-Nsn and AlrL-Nsn; Table S2). The distances between symmetric landmarks all showed the highest correlations (Table S2), consistent with general knowledge about facial symmetry. Compared with females, males on average had greater centroid size (P<1.0×10−300) and on average 5 mm larger inter-landmark distances (Table S3). These values are similar to the sex-specific ranges previously reported from cranial data . After adjusting for the effect of centroid size, the most characteristic sex effect was that males on average had larger noses than females (AlrL-Prn and AlrR-Prn; 4 mm difference; P<1.0×10−141; Table S3). This sex difference is also illustrated using a thin plate splines deformation (Figure S1), showing a larger nose size in males (Figure S1C). Increased age was most significantly associated with increased bizygomatic distance (ZygR-ZygL, P=1.9×10−111, Table S3). This is unlikely to be explained by the amount of subcutaneous fat in elderly people since the zygion landmarks were placed on the cortex of the bone. Heritability of 36 inter-landmark distances was estimated in 79 MZ and 90 DZ Australian twins (range 0.46–0.79, mean 0.67; Table S4). The phenotypic correlations in MZ pairs (r=0.71) were on average much higher than those in DZ pairs (r=0.28; Table S4). These estimates are consistent with previous facial morphology studies ,  and suggest reasonably high reliability of the derived phenotypes.
We conducted a discovery phase GWAS in the combined sample (N=5,388) from RS1, RS2, QTIMS, SHIP, and SHIP-TREND where facial shape phenotypes were all derived from comparable 3D head MRIs and using the same approach. We tested 2,558,979 autosomal SNPs for association with 48 facial phenotypes, including the centroid size, 36 inter-landmark Euclidean distances, and 11 shape PCs. Q-Q plots (Figure 3) and genomic inflation factors (λ<1.03) did not show any sign of inflation of the test statistics. Since many phenotypes tested were highly correlated (Table S1, Table S2), and Bonferroni correction of 48 traits would obviously be too stringent, we considered the traditional threshold P<5×10−8 as the significance threshold in the discovery phase. The GWAS revealed five independent loci at P<5×10−8 (Table 2). All these signals were observed for inter-landmark distances and most involved the nasion landmark. No genome-wide significant associations were found for individual PCs or for the centroid size. The genome-wide significantly associated SNPs were located either within (missense or intronic) or very close to (<10 kb) the following five genes: PRDM16, PAX3, TP63, C5orf50, and COL17A1. Notably, our finding at PAX3 reflects an independent discovery from a parallel GWAS of facial features recently reported by Paternoster et al. , which identified an intronic SNP of PAX3, rs7559271, in association with the nasion position. In our study, three different SNPs, rs16863422, rs12694574, and rs974448 at PAX3 on chromosome 2q35, in the same linkage-disequilibrium (LD) block containing rs7559271, were associated with the distance between the eyeballs and nasion (7.1×10−7<P<1.6×10−8 for EyeR-Nsn and EyeL-Nsn; Table 2, Figure 4B). The SNP rs7559271 from Paternoster et al. was nominally significantly associated with EyeR-Nsn (P=0.008) and EyeL-Nsn (P=0.004) in our data. We therefore independently confirm a role for PAX3 in contributing to facial shape variation at the genome-wide scale, which provides confidence in the remainder of our GWAS findings. Multiple intronic SNPs of PRDM16 on chromosome 1p36.23-p33 were associated with nose width and nose height (such as rs4648379, 2.5×10−7<P<1.1×10−8 for AlrL-Prn and AlrR-Prn; Table 2, Figure 4A). An intronic SNP of TP63 on chromosome 3q28, rs17447439, showed association with the distance between eyeballs (P=4.4×10−8 for EyeR-EyeL, Table 2, Figure 4C). A SNP rs6555969 very close to C5orf50 on chromosome 5q35.1 was associated with nasion position (5.8×10−7<P<1.2×10−9 for ZygR-Nsn, ZygL-Nsn, EyeR-Nsn, and EyeL-Nsn; Table 2, Figure 4D). A missense SNP rs805722 in COL17A1 on chromosome 10q24.3 was also associated with the distance between eyeballs and nasion (6.5×10−7<P<4.0×10−8 for EyeR-Nsn and EyeL-Nsn; Table 2, Figure 4E).
We attempted to replicate our GWAS findings in the SYS cohort (N=568). Unlike the other (adult) cohorts, the SYS cohort is an adolescent one, with a mean age of 15 and a minimum age of 12 years. This may potentially lead to false negative replications since the face continues to develop and ossify throughout adolescence in a different manner than in the adult, especially in male adolescents . On the other hand, the recent identification of PAX3  was based on an adolescent cohort. Our independent identification of PAX3 in adults here demonstrates that at least some genetic effects on facial features that manifest in adolescence remain detectable in adulthood. The association signal at PAX3, however, did not replicate in SYS, possibly due to the small sample size available in this replication cohort. Likewise, the signals at PRDM16 and TP63 were not replicated in SYS. Two other loci, C5orf50 and COL17A1, were successfully replicated for the same phenotypes (0.032<P<7.5×10−5 for C5orf50 and 9.7×10−4<P<5.9×10−4 for COL17A1; Table 2). Besides the exact replication, association signals at C5orf50 and COL17A1 were observed for multiple phenotypes, i.e. 16.0% and 18.1% of the 1,540 pair-wise distances between all 56 landmarks available in SYS  (Table 2).
In addition to the direct replication of MRI-based phenotypes in the SYS cohort, we sought further supporting evidence of association in a combined data set of two additional samples from the UK (TwinsUK, N=1,366) and Australia (BLTS, N=2,137) where we localized eight facial landmarks on 2D portrait photos (illustrated in Figure 5A). Raw landmark coordinates showed significant differences not only in position and orientation but also in size (Figure 5B); we thus used full PS including rescaling to remove these differences (Figure 5C). Note that the inter-landmark distances from 2D photos, with or without rescaling, do not represent the absolute distance in terms of millimeters, as those from 3D MRIs do. Furthermore, the fact that 2D data in general miss a complete dimension may potentially lead to false negative replications. Note also that the twin correlations for the inter-landmark distances, estimated based on 2D photos, were in general much lower than those from 3D MRIs (r=0.42 in 218 MZ pairs, r=0.16 in 533 DZ pairs; TwinsUK and BLTS combined sample), indicating that these phenotypes were more noisy than those derived from the 3D images. In spite of these limitations, we observed nominally significant associations for approximately the same phenotypes for 2 of the 5 loci identified from our GWAS, TP63 and C5orf50 (P<0.05; Table 2). The associations at these 2 loci were also observed for multiple phenotypes, i.e. P<0.05 for 17.9–21.4% of all 28 inter-landmark distances (Table 2). Thus, except for PRDM16 and PAX3, all loci identified with genome-wide significance in the discovery cohorts were replicated in 3D MRI (SYS) or 2D photo (TwinsUK, BLTS) analyses. For PAX3 there was a significant association between rs974448 and the distance between the eyeballs in the 2D data (beta=0.30, se=0.15, P=0.045, data not shown, note in Table 2 the results for PAX3 are shown for Eye-Nsn phenotypes). In our discovery phase GWAS a total of 102 SNPs at 29 distinct loci showed significant or suggestive evidence of association (P<5×10−7) with various facial phenotypes (Table S5). We provide raw genotype and respective phenotype data for all SNPs that revealed genome-wide significant and suggestive evidence (Table S6) to make our most important findings publically available to other researchers who may wish to explore them further.
Finally, we re-investigated the potential association between SNPs previously involved in NSCL/P and normal facial shape variation in our discovery cohorts (Table 3). For this purpose, we tested associations between facial phenotypes and 11 SNPs ascertained in our previous candidate gene study , originally discovered in previous GWAS on NSCL/P , , , . Five SNPs at 4 candidate NSCL/P loci were significantly associated with normal facial phenotypes even after a strict Bonferroni correction of multiple testing of all 48 correlated phenotypes (Table 3). These included rs7590268 at 2p21, rs16903544 and rs987525 at 8q24, rs9574565 at 13q31, and rs227731 at 17q22. All these SNPs were also associated with over 10% of 48 facial phenotypes at P<0.05, where rs987525 at 8q24 was associated with over half of the studied phenotypes (52.08%, Table 3). In addition, the SNP rs642961 at chromosome 1q32 was associated with 27.1% of the studied phenotypes at P<0.05, although the minimal P value was not significant after the over-conservative Bonferroni correction. The SNP rs1258763 at 15q13 was nominally significantly associated with nose-width (P=0.03 for AlrR-AlrL, Table 3), although not significant after the Bonferroni correction. These findings strongly suggest that genetic variants involved in NSCL/P also influence normal facial shape variation.
We identified five independent loci at 1p36.23-p33, 2q35, 3q28, 5q35.1, and 10q24.3 consisting of common DNA variants associated with normal facial shape phenotypes in individuals of European ancestry. Candidate genes at these loci include PRDM16 (PR domain containing 16), PAX3 (paired box 3), TP63 (tumor protein p63), C5orf50 (chromosome 5 open reading frame 50), and COL17A1 (collagen, type XVII, alpha 1). In addition to our GWA findings, we confirmed links between NSCL/P cleft associated SNPs at 2p21, 8q24, 13q31, and 17q22 and normal human facial shape variation based on a candidate gene approach.
From a statistical perspective, the most robust result was the one at the PAX3 locus. We identified this gene in our discovery GWAS, a finding independent of, but consistent with, a recent GWAS . Although the association with the same set of phenotypes failed replication in our replication cohorts, the identification of the same locus at the genome-wide significant level from completely independent GWASs cannot be coincidence. This provides strong statistical evidence that the PAX3 gene is indeed involved in facial morphology. The signal observed at C5orf50 at 5q35.1 in association with the nasion position was successfully replicated in both SYS using 3D MRI derived phenotypes under similar (buit not identical) methodology as well as in a combined sample of TwinsUK and BLTS using 2D photograph derived phenotypes. The association signal observed at COL17A1 was replicated only in SYS (3D MRI) and that at TP63 was replicated only in TwinsUK and BLTS (2D photos). The signal observed at PRDM16 was not replicated in our replication cohorts. The failure in replication for some of our GWAS findings may be explained by physical limitations in our replication cohorts as discussed in detail below.
Three of the five loci identified in this study have previously been shown to play an essential role in craniofacial development; in particular, they have been implicated in orofacial clefting phenotypes in mice or humans. PAX3 encodes a developmentally important transcription factor expressed in neural crest cells, a multipotent cell population contributing to most differentiated cell types in the vertebrate face. In humans, PAX3 is one of six genes mutated in Waardenburg syndrome, which is characterized by a range of neural crest related phenotypes including minor facial dysmorphism manifest as a broad nasal root and an increased distance between the medial canthi or corners of the eye (telecanthus) . Studies in mice have demonstrated that failure to down regulate PAX3 during neural crest differentiation leads to cleft palate, due to inhibitory effects on osteogenesis . Of particular relevance to this study, a recent GWAS detected an association between PAX3 and position of the nasion .
PRDM16 was previously identified as a SMAD binding partner; it is thought to act in downstream mediation of TGFβ signaling in developing orofacial tissues . Consistent with this role, PRDM16 is expressed in both the primary and secondary palate and the nasal septum in mouse embryos . Functional studies in mice confirm a role in craniofacial development, with an N-ethyl-N-nitrosourea-induced mutation in PRDM16 resulting in cleft palate and other craniofacial defects including mandibular hypoplasia . Moreover, variants at the human PRDM16 locus have been implicated in NSCL/P .
TP63 encodes a transcription factor belonging to the p53 family, and plays important roles in orchestrating developmental signaling and epithelial morphogenesis. Heterozygous mutations in human TP63 are associated with a number of allelic syndromes characterized by orofacial defects, including Ectrodactyly-Ectodermal dysplasia-Cleft lip/palate and Ankyloblepharon-Ectodermal dysplasia-Clefting . Furthermore, TP63 has been implicated in human NSCL/P , and null mice recapitulate the human orofacial clefting phenotypes .
The remaining two loci identified in the discovery sample and replicated in both the SYS and TwinsUK & BLTS samples have no previously known direct involvement in craniofacial development to date. C5orf50 at 5q35.1 is predicted to encode an uncharacterized transmembrane protein, which lies within a 1.24 Mb duplicated region in a patient with preaxial polydactyly and holoprosencephaly (HPE), a defect in development of the forebrain and midface . The most likely candidate in the duplicated region is FBXW11, a gene with links to sonic hedgehog signaling, the main pathway affected in HPE . It is therefore possible that variants at the C5orf50 locus influences craniofacial patterning through effects on FBXW11 expression, although it is also feasible that the protein encoded by C5orf50 has a novel, and more direct, effect on the face. Mutations in COL17A1 cause Junctional epidermolysis bullosa (JEB), a genetic blistering condition , however, there is no evidence to date for a direct involvement of this gene in craniofacial morphogenesis. Our data suggest that COL17A1 may play an as yet undefined role in patterning facial tissues. However, the association signal observed for COL17A1 at 10q24.3 spans a 300 kb region (105.7 Mb–106 Mb) and also harbors other genes including SLK, C10orf78 and C10orf79. Thus, we cannot exclude the possibility that these genes are responsible for the observed association.
Many medical-genetic syndromes show a clear connection between genetic alteration and typical facial gestalt , hence genes involved in affected individuals may also contribute to normal variations in facial shape. Our previous study of 11 NSCL/P associated SNPs  showed some borderline significance for association with nose-width and bizygomatic distance but inconsistent effect was observed in two populations studied (Rotterdam and Essen). This discrepancy may be partially explained by sample size and different sources of facial phenotype, namely 3D MRI in the Rotterdam Study and 2D portrait photos in Essen. In the 2D facial pictures in the Essen sample, for instance, the bizygomatic distance was defined indirectly by neighboring landmarks of the face . In the current study using 3D MRI data in a larger sample (N=5,388), multiple SNPs showed significant association with multiple facial phenotypes, even after an over-conservative Bonferroni correction. Thus, in the present study we established clear links between NSCL/P associated SNPs at 2p21, 8q24, 13q31, and 17q22 and normal facial shape phenotypes, including nose width and facial width, in general populations of European descent. This is in line with previous evidence showing that unaffected relatives of NSCL/P cleft patients have wider upper faces and noses than unrelated individuals , . Together with our GWAS findings at three loci previously known to play a role in orofacial clefting, our data strongly suggest that genetic variants associated with NSCL/P also influence normal facial shape variation.
This study is not without limitations. The limited number of landmarks used in this study cannot capture the full range of the complex 3D shape variation in the face. This is partly due to the physical limitation of our MRI data that miss the lower part of the face and partly due to other factors such as partial incompatibility of 3D and 2D image sources for phenotype extraction. Consequently, some of the significant associations based on 3D distances could not be tested in the 2D photo analysis. For instance, the zygion landmarks available in 3D MRI could not be successfully derived in 2D photos. Further, the precision of phenotypes derived from 2D photos is expected to be lower than that from 3D MRIs. This is indicated by the lower twin correlations in 2D photos than in 3D MRI. Phenotypic noise in 2D photos may arise from slight differences in face orientation, an effect that cannot be removed by PS without measuring the 3rd coordinate. Furthermore, different image sizes and pixel resolutions in 2D photos may also influence the phenotyping results. Thus, we used the 2D photo analysis to provide supporting information but cannot be considered as an exact replication. Another concern is that the facial landmarks from the SYS cohort were derived in a previous study  based on slightly different definitions compared with the ones from the five discovery cohorts. This may potentially lead to some heterogeneity in replication results. Furthermore, the SYS cohort consists of adolescents. Some of us have shown previously that several facial features continue to change during the male (but not female) adolescents . This study included only samples of European ancestry, which reduces the potential risk of false positive findings due to systematic genetic differences between different populations. On the other hand, further investigation in world-wide samples is required to generalize our findings to populations other than Europeans, and to investigate the genetic basis of particular facial phenotypes that are absent from Europeans. In addition, we have only focused on common variants (MAF>3%); further investigations of less common and/or quite rare variants as for instance available from next generation sequencing data may provide a more complete figure on the genetic basis of facial morphology.
In spite of these limitations we have been able to demonstrate that a phenotype as complex as human facial morphology can be successfully investigated via the GWAS approach with a moderately large sample size. Three of the five loci highlighted here map to known developmental genes with a previously demonstrated role in craniofacial patterning, one of which has been unequivocally associated with nasion position in a recent independent GWAS . The remaining two loci map to or close to C5orf50 and COL17A1, neither of which have previously been implicated in facial development. The associated DNA variants may either affect neighboring genes, or alternatively identify C5orf50, and COL17A1 as potential new players in the molecular regulation of facial patterning. Overall, we have uncovered five genetic loci that contribute to normal differences in facial shape, representing a significant advance in our knowledge of the genetic determination of facial morphology. Our findings may serve as a starting point for future studies, which may test for allele specific expression of these candidate genes and re-sequence their coding regions to identify possible functional variants. Moreover, our data also highlight that the high heritability of facial shape phenotypes (as estimated here and elsewhere), similar to that of adult body height , involves many common DNA variants with relatively small phenotypic effects. Future GWAS on the facial phenotype should therefore employ increased sample sizes as this has helped to identify more genes for many other complex human phenotypes such as height  and various human diseases. Combined with the emerging advances in 3D imaging techniques, this offers the poteintial to advance our understanding of the complex molecular interactions governing both normal and pathological variations in facial shape.
The RS is an ongoing population-based prospective study including a main cohort RS-I  and two extensions RS-II and RS-III , , including 15,000 participants altogether, of whom 12,000 have GWAS data. Collection and purification of DNA have been described in detail previously . A subset of participants were scanned on a 1.5 T General Electric MRI unit (GE Healthcare, Milwaukee, WI, USA), using an imaging protocol including a 3D T1-weighted fast RF gradient recalled acquisition in steady state with an inversion recovery prepulse. The following parameters were used: 192 slices, a resolution of 0.49×0.49×0.8 mm3 (up sampled from 0.6×0.7×0.8 mm3 using zero padding in the frequency domain), a repetition time (TR) of 13.8 ms, an echo time (TE) of 2.8 ms, an inversion time (TI) of 400 ms, and a flip angle of 20°. More details on image acquisition can be found elsewhere . The Medical Ethics Committee of the Erasmus MC, University Medical Center Rotterdam, approved the study protocol, and all participants provided written informed consent. Principal components analysis of SNP microarray data was used to identify ancestry outliers. These were removed before further analyses, and the present sample is of exclusively northern/western European origin. The current study included 3,215 RS participants who had both SNP microarray data and 3D MRI. These participants were considered here as two cohorts (RS1 N=2,470 and RS2 N=745) as they were scanned and genotyped at different times.
Adolescent twins and their siblings were recruited over a period of sixteen years into the BLTS at 12, 14 and 16 years, as detailed elsewhere  and as young adults into the QTIMS , . The present study includes a sub-sample of 545 young adults (aged 20–30 years, M=23.7±2.3 years; 79 MZ and 90 DZ pairs, 110 unpaired twins, and 97 singletons, from a total of 332 families) from QTIMS with 3D MRIs, and 2,137 adolescents (aged 10–22 years, M=15.6±1.5 years; 311 MZ and 530 DZ pairs, 44 unpaired twins and 411 singletons, from a total of 1,038 families) from BLTS with 2D portrait photos. 3D T1-weighted MR images were collected at the Centre for Advanced Imaging, University of Queensland, using a 4T Bruker Medspec whole body scanner (Bruker Medical, Ettingen, Germany) . 2D portrait photos were taken from a distance of 1–2 meters for identification, with no specific instruction given to smile. Those who had both 3D MRI scans and 2D photos were included in discovery GWAS and excluded from the replication analysis in 2D photos. Over 70% were digital with the remainder being scanned from high quality film. The study was approved by the Human Research Ethics Committee, Queensland Institute of Medical Research. Informed consent was obtained from all participants (or parent/guardian for those aged less than 18 years).
The SHIP is a longitudinal population based cohort study assessing the prevalence and incidence of common, population relevant diseases and their risk factors with examinations at baseline (SHIP-0, 1997–2001), 5-year-follow-Up (SHIP-1, 2002–2006) and an ongoing 10-year-follow-Up (SHIP-2, 2008–2012) , . Data collection from the baseline sample included 4,308 subjects. A new cohort targeted 5,000 participants (SHIP-TREND) has been started parallel to the SHIP-2-Follow-Up. In addition to the baseline examinations, participants of SHIP-2 and SHIP-TREND also had a whole-body MRI scan . MRI examinations were performed on a 1.5T MR imager (Magnetom Avanto; Siemens Medical Systems, Erlangen, Germany). Head scans were taken with an axial ultra-fast gradient echo sequence (T1 MPRage, TE 1900.0, TR 3.4, Flip angle 15°, 1.0×1.0×1.0 mm voxel size). The present study includes 797 SHIP as well as 831 SHIP-TREND participants which had both SNP genotyping data and 3D MRI. The medical ethics committee of University of Greifswald approved the study protocol, and oral and written informed consents were obtained from each of the study participants.
Adolescent sibpairs (12 to 18 years of age) were recruited from a French-Canadian population with a known founder effect living in the Saguenay-Lac-Saint-Jean region of Quebec, Canada in the context of the ongoing Saguenay Youth Study . Local ethics committee approved the study; the parents and adolescent participants gave informed consent and assent, respectively. MRI was acquired on a Phillips 1.0-T magnet using the following parameters: 3D radio frequency spoiled gradient-echo scan with 140–160 slices, an isotropic resolution of 1 mm, TR 25 ms, TE 5 ms, and flip angle of 30°. Outlying individuals including those with putative Indigenous American admixture were excluded based on genetic outlier analysis . The current study contains 568 adolescents with MRI and SNP data.
The TwinsUK cohort is unselected for any disease and is representative of the general UK population . All were volunteers, recruited through national media campaigns. Written informed consent was obtained from every participant. Population substructure and admixture was excluded using eigenvector analysis on SNP microarray data. The current study included 1,366 individuals with 2D portrait photos and SNP microarray data.
In our discovery cohorts, since the lower part of the face was not available from the MRIs, we focused on nine landmarks of the upper face (Figure 1). These included Right (ZygR) and left (ZygL) zygion: the most lateral point located on the cortex of the zygomatic arches; right (EyeR) and left (EyeL) eyeball: the middle point of the eyeball; right (AlrR) and left (AlrL) alare: the most lateral point on the surface of the ala nasi; nasion (Nsn): the skin point where the bridge of the nose meets the forehead; pronasale (Prn): the most anterior tip of the nose; subnasale (Sbn): the point where the base of the nasal septum meets the philtrum. Although these landmarks provide only a very sparse representation of the facial shape, they cover most prominent facial features and are easy to interpret and compare to other studies , , . Furthermore, these landmarks could be measured with higher accuracy from images than most semilandmarks .
The coordinates of these nine landmarks were derived with an automated technique as described previously , which uses image registration to transfer predefined landmarks from a limited set of annotated images to an unmarked image. The manual annotation was based on landmark definitions from the anthropology literature , which were adapted for application to T1-weighted MR images of the head. None of the MRI showed distortions in a visual inspection. Furthermore, the automatically localized landmark positions were robust against the number of samples included. The test-retest correlations based on a subset of 40 subjects from QTIMS who were scanned twice were high (r>0.99).
In the SYS cohort, in total 56 facial landmarks were available from a previous quantitative analysis of craniofacial morphology using 3D MRI . In brief, an average MRI was constructed using non-rigid image registration. The surface of this average image represents the mean facial features and was then annotated with 56 landmarks and semi-landmarks. These landmarks were then warped using the nonlinear transformation that maps each subject to the average. This allows for automatic identification of the different craniofacial landmarks.
We defined eight landmarks in 2D portrait photos that approximately correspond to the respective landmarks ascertained from our 3D MRIs. These include EyeL, EyeR, Prn, AlrL, AlrR, Nsn, earlobe left (EarL), and earlobe right (EarR) (Figure 5A). Note the Sbn, ZygL and ZygR landmarks available in 3D MRIs could not derived in 2D photos. We developed an algorithm to locate these landmarks in 2D portrait images and implemented it in an in-house C++ program. Briefly, the algorithm first recognizes the face layout within an image by matching a face template. It then recognizes eyes, nose, and ears by matching corresponding templates. The template matching routines were based on external open source computer vision library, OpenCV 2.3.1 (http://sourceforge.net/projects/opencvlibrary/). The automatically identified landmarks were then manually adjusted by 5 research assistants on a standard computer screen.
We used un-scaled PS, or partial PS , , to superimpose the landmarks from the 3D MRIs in the discovery cohorts onto a consensus 3D Euclidean space. Unlike full PS, partial PS only re-positions and re-orientates but does not rescale the landmark configurations; thus, it has no effect on the Euclidean distances between landmarks as measured in terms of millimeters from MRIs. Keeping the absolute inter-landmark distances allows us to interpret the association results more directly. Furthermore, the full PS has been criticized for introducing artificial correlations between landmarks . We considered the centroid size as a measurement of face size, and it was significantly correlated with absolute head volume (r=0.95). We derived 11 principal components (PCs) from the superimposed landmarks, each explaining at least 1% of the total phenotypic variance. We also derived 36 Euclidean distances between all pairs of landmarks. Thus 48 phenotypes were included in our GWAS, including centroid size, 11 PCs, and 36 inter-landmark distances. All phenotypes were approximately normally distributed and outliers (>3sd) were removed. Deformation approaches including the use of transformational grids provide an alternate way to study shape difference. Thin plate splines (TPS)  depicts the deformation geometrically, where the total deformation is decomposed into several orthogonal components to localize and illustrate the shape differences. We used TPS to illustrate the facial shape differences between males and females using the tpsgrid function in R library shapes.
For 3D MRI data in SYS, we used the 56 landmarks derived in a previous study and calculated 1,540 Euclidean distances between all pairs of landmarks. These distances were considered as phenotypes in our replication analysis of GWAS findings. We also chose a subset of nine landmarks most closely resembled those used for the current study for exact replication.
Since the size of the face vary substantially between 2D portrait images, we used the full PS  to also remove the scaling differences between landmark configurations. Note that the inter-landmark distances from 2D photos do not represent the absolute distances in terms of millimeters regardless of whether full or partial PS was used. After superimposition, we calculated 28 Euclidean distances between all pairs of the 8 landmarks, which were considered as phenotypes in the replication analysis. The PS analyses were performed with CRAN package shapes developed by Ian Dryden .
By clarifying which facial features are under strong genetic control, we should be better able to identify specific genes that influence facial variation. Heritability estimates are also important indicators of the phenotype quality. Using QTIMS (79 MZ pairs, 90 DZ pairs) heritability analysis was carried out in Mx  using full information maximum likelihood estimation of additive genetic variance (i.e. heritability), common environmental variance, and unique environmental variance. Sex and age were included as covariates. Phenotypic correlations were estimated in BLTS (311 MZ pairs, 90 DZ pairs) and in TwinsUK (93 MZ pairs, 352 DZ pairs) where the facial shape phenotypes were derived from 2D photos.
Details of SNP microarray genotyping, quality control and genotype imputation are described in prior GWAS conducted in RS , QTIMS and BLTS , SHIP , SYS , and TwinsUK . In brief, DNA samples from the RS, BTNS, SYS and TwinsUK cohorts were genotyped using the Human 500–610 Quad Arrays of Illumina and samples from SHIP were genotyped using the Genome-Wide Human SNP Array 6.0 of Affymetrix and HumanOmni2.5 of Illumina, respectively. Genotyping of the SHIP-TREND probands (n=986) was performed using the Illumina HumanOmni2.5-Quad, which has not been reported previously and described here as follows. DNA from whole blood was prepared using the Gentra Puregene Blood Kit (Qiagen, Hilden, Germany) according to the manufacturer's protocol. Purity and concentration of DNA was determined using a NanoDrop ND-1000 UV-Vis Spectrophotometer (Thermo Scientific). The integrity of all DNA preparations was validated by electrophoresis using 0.8% agarose-1x TBE gels stained with ethidium bromide. Subsequent sample processing and array hybridization was performed as described by the manufacturer (Illumina) at the Helmholtz Zentrum München. Genotypes were called with the GenCall algorithm of GenomeStudio Genotyping Module v1.0. Arrays with a call rate below 94%, duplicate samples as identified by estimated IBD as well as individuals with reported and genotyped gender mismatch were excluded. The final sample call rate was 99.51%. Imputation of genotypes in the SHIP-TREND cohort was performed with the software IMPUTE v18.104.22.168 against the HapMap II (CEU v22, Build 36) reference panel. 667,024 SNPs were excluded before imputation (HWE p-value≤0.0001, call rate ≤0.95, monomorphic SNPs) and 366 SNPs were removed after imputation due to duplicate RSID but different positions. The total number of SNPs after imputation and quality control was 3,437,411. The genetic data analysis workflow was created using the Software InforSense. Genetic data were stored using the database Caché (InterSystems). After SNP imputation to the HapMap Phase II CEU reference panel (Build 36) and quality control, 2,558,979 autosomal SNPs were common in all discovery cohorts and used for analyses.
We conducted discovery phase GWAS in a combined set of all discovery cohorts (RS1, RS2, QTIM, SHIP, SHIP-Trend) for 48 facial shape phenotypes. Imputed GWAS data in all discovery cohorts were merged according to the positive strand. We tested 2,558,979 autosomal SNPs with linear regression (adjusted for sex, age, EIGENSTRAT-derived ancestry informative covariates , plus any additional ancestry informative covariates as appropriate) in GenABEL . The centroid size was adjusted in the analysis of inter-landmark distances. SNPs with MAF<3%, overall call rate <95%, and HWE P<1×10−3 were not considered for report. Genomic inflation factors were estimated in range 1.0–1.03 for all studied phenotypes. The observed P-values were Q-Q plotted against the expected P-values at −log10 scale. We considered the traditional threshold of 5×10−8 as being genome-wide significant since many phenotypes were highly correlated. All SNPs in this study were annotated based on NCBI build 36.3.
The linear modeling used here separately analyzes each facial phenotype. It is also possible to derive a global P-value for testing the shape difference between different genotype groups using other approaches, such as the Euclidean Distance Matrix Analysis (EDMA) ,  and the multivariate analysis of variance (MANOVA) . The EDMA computes a score of the maximal ratio  or difference  between the mean shapes estimated in two groups. Since this score does not follow a known distribution, the statistical significance is derived by bootstrapping all landmark configurations. In the context of GWAS, this bootstrap procedure should be conducted for every SNP, which turned out to be computationally heavy when we attempted to implement it at the genome-wide scale. In addition, EDMA is less flexible than linear modeling when the effects of covariates are to be adjusted and when more than two genotype groups are to be compared. The MANOVA is a classic statistical method for analysis of multiple correlated response variables, which has been shown to be useful in GWAS . We implemented MANOVA for GWAS in R and conducted a GWAS for the residuals of the 11 facial shape PCs after regressing out the effect of sex, age, and population stratification. However, no significant signal (P<5×10−8) was observed for SNPs with MAF>3% (results not shown).
All SNPs with P values<5×10−8 in our discovery phase GWAS were sought for replication in SYS, TwinsUK, and BLTS. Promising SNPs were tested for association with 1,054 inter-landmark distances in SYS and 28 inter-landmark distances in a combined sample of TwinsUK and BLTS assuming additive allelic effect adjusted for sex and age using MERLIN , which also takes into account family relationships. We report the association results for the same phenotypes as discovered in GWAS as exact replication. In addition, for each SNP we report the percentage of significantly (P<0.05) associated phenotypes, which is expected to be lower than 5% under the null hypothesis of no association. For the analysis of 11 NSCL/P associated SNPs in our discovery cohorts, we additionally Bonferroni corrected the P values for 48 correlated phenotypes since no specific facial phenotypes were selected for replication.
Thin plate spline deformation illustrating facial shape differences in males compared to females in discovery cohorts (N=5388). The pixel information obtained from the mean shape of males was mapped to that of females. The deformed images illustrate the difference between the mean shpae of males (the curved plates) compared to that of females (imaginary flat plates). A. a 3D view of the mean facial shape of all individuals in the discovery cohorts before deformation; B. side projection of the deformed grid; C. front projection of the deformed grid; D. up-down projection of the deformed grid.
Correlation between PC and Euclidean distances in discovery cohorts. The color shade is independent between columns.
Correlation matrix between pair-wise Euclidean distances and size in discovery cohorts.
Effect of sex and age on facial shape in discovery cohorts. Distances are presented in millimeters. P values were adjusted for centroid size.
Heritability of facial shape phenotypes derived from 3D MRI in QTIMS. Twin correlations and proportions of variance due to additive genetic (A), common environmental (C), and unique environmental (E) influences, shown with 95% confidence intervals (age and sex adjusted).
SNPs (n=102) associated (P<5e-7) with facial shape phenotypes in discovery phase GWAS. Trait, the phenotype for which the minimal P value was obtained. MinP, the minimal P value.
Raw genotype and respective phenotype data for all SNPs that revealed genome-wide significant and suggestive evidence.
We thank all study-participants, volunteer twins, and their families of the Rotterdam Study, the Queensland Twin Imaging Study, the Study of Health In Pomerania, the Saguenay Youth Study, the Brisbane Longitudinal Twin Study, and the St. Thomas' UK adult twin registry.
The RS authors thank Pascal Arp, Mila Jhamai, Marijn Verkerk, Lizbeth Herrera, and Marjolein Peters for their help in creating the GWAS database; Karol Estrada and Maksim V. Struchalin for their support in creation and analysis of imputed data; George Maat for advice in locating anatomical landmarks on MRI; and Lakshmi Chaitanya, Arwin F. Ralf, Iris Kokmeijer, Silke Brauer, and Lisa Boehme for adjusting landmark locations on 2D photos. Monique Breteler is acknowledged for her interest and support in an early phase of this project.
The QTIMS and BLTS authors thank Kori Johnson and the radiographers for acquiring and pre-processing of the 3D images; Marlene Grace and Ann Eldridge for twin recruitment and collection of the 2D photos; Anjali Henders, Megan Campbell, Lisa Bowdler, Steven Crooks, and staff of the Molecular Epidemiology Laboratory for DNA sample processing and preparation; Harry Beeby, David Smyth, and Daniel Park for IT support; and Dale R. Nyholt and especially Scott Gordon for their substantial efforts involving the QC and preparation of the GWA datasets.
The SHIP authors are grateful to Mario Stanke for the opportunity to use his Server Cluster for the extraction of the facial landmarks and for the SNP imputation, to Alexander Teumer for his support with the software compilation, as well as to Holger Prokisch and Thomas Meitinger (Helmholtz Zentrum München) for genotyping of the SHIP-TREND cohort.
The SYS authors thank all colleagues and staff for their contributions in designing the protocol, acquiring and analyzing the data. Computations for the SYS sample were performed on the SciNet supercomputer at the SciNet HPC Consortium.
This work was supported by in part by funds from the Netherlands Forensic Institute and received additional support by a grant from the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NWO) within the framework of the Forensic Genomics Consortium Netherlands. The Rotterdam Study is funded by Erasmus Medical Center and Erasmus University, Rotterdam; Netherlands Organization for the Health Research and Development (ZonMw); the Research Institute for Diseases in the Elderly (RIDE); the Ministry of Education, Culture, and Science; the Ministry for Health, Welfare, and Sports; the European Commission (DG XII); and the Municipality of Rotterdam. The generation and management of GWAS genotype data for the Rotterdam Study is supported by the Netherlands Organization of Scientific Research NWO Investments (175.010.2005.011, 911-03-012). This study is funded by the Research Institute for Diseases in the Elderly (014-93-015; RIDE2), the Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO) project 050-060-810. QTIMS is funded by the National Institutes of Health, United States (HD50735), and the National Health and Medical Research Council (NHMRC), Australia (496682). We acknowledge support from the Australian Research Council (A7960034, A79906588, A79801419, DP0212016, DP0343921, DP0664638, DP1093900) and NHMRC (900536, 930223, 950998, 981339, 983002, 961061, 983002, 241944, 389875, 552485, 613608) for collection of the 2D photos. Genotyping was funded by the NHMRC (Medical Bioinformatics Genomics Proteomics Program, 389891). We acknowledge funding from ARC Linkage Project: “Molecular photofitting for criminal investigations” (LP110100121). SHIP is part of the Community Medicine Research net of the University of Greifswald, Germany, which is funded by the Federal Ministry of Education and Research (grants 01ZZ9603, 01ZZ0103, and 01ZZ0403), the Ministry of Cultural Affairs, as well as the Social Ministry of the Federal State of Mecklenburg, West Pomerania. Genome-wide data have been supported by the Federal Ministry of Education and Research (grant 03ZIK012) and a joint grant from Siemens Healthcare, Erlangen, Germany, and the Federal State of Mecklenburg, West Pomerania. Whole-body MR imaging was supported by a joint grant from Siemens Healthcare, Erlangen, Germany, and the Federal State of Mecklenburg, West Pomerania. The University of Greifswald is a member of the “Center of Knowledge Interchange” program of the Siemens AG. CS was supported by funds from the Deutsche Forschungsgemeinschaft (GRK-840). The Saguenay Youth Study project is funded by the Canadian Institutes of Health Research (TP, ZP), Heart and Stroke Foundation of Quebec (ZP), and the Canadian Foundation for Innovation (ZP). SciNet is funded by the Canada Foundation for Innovation under the auspices of Compute Canada, the Government of Ontario, Ontario Research Fund–Research Excellence, and the University of Toronto. The Twins UK study was funded by the Wellcome Trust, European Community's Seventh Framework Program (FP7/2007-2013)/grant agreement HEALTH-F2-2008-201865-GEFOS and (FP7/2007-2013), ENGAGE project grant agreement HEALTH-F4-2007-201413, and the FP-5 GenomEUtwin Project (QLG2-CT-2002-01254). The Twins UK study also receives support from the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's and St. Thomas' NHS Foundation Trust in partnership with King's College London. TDS is an NIHR Senior Investigator. The Twins UK study also received support from a Biotechnology and Biological Sciences Research Council (BBSRC) project grant (G20234) and a U.S. National Institutes of Health (NIH)/National Eye Institute (NEI) grant (1RO1EY018246), and genotyping was supported by the NIH Center for Inherited Disease Research. The Twins UK study also received support from the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's and St. Thomas' National Health Service Foundation Trust partnering with King's College London. Identitas Inc. sponsors the VisiGen Consortium via a research grant to a number of the respective academic institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.